Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

Study Overview
=================
Brief Summary
-----------------
This research aims to improve our knowledge of the epidemiology of patients consulting in the COvid-19 Possible REspiratory Units (RECOP unit). Indeed, the epidemic linked to COVID-19 affects France and impacts its health system. The reception of all intermediate patients will be on the Emergency Structures (SU). Indeed, the French healthcare system centralizes unscheduled urgent care on the ER. The aspecific respiratory symptomatology in intermediate patients indicates them all the more at an admission to SU or the diagnostic approach to respiratory difficulty may be carried out. A central issue of this diagnostic strategy will be to be rapid, since the diagnosis will have to be made in the context of significant flows, with a need to quickly refer patients to the most suitable downstream service, while limiting the risk contamination of caregivers and vulnerable patients if a COVID-19 + patient is admitted to an unsuitable service. However, virological tests do not currently allow rapid results for COVID-19. Research project of investigatory aims to develop a predictive model of the risk of being COVID-19 positive for patients admitted to the emergency room for acute dyspnea.

Official Title
-----------------
Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea

Conditions
-----------------
Emergencies

Intervention / Treatment
-----------------
* Other: RECOP unit patient


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All patients over 15 years admitted to the RECOP unit for dyspnea Exclusion Criteria: Patient admitted to shock for respiratory distress requiring immediate respiratory support. Patient under justice safeguard

Ages Eligible for Study
-----------------
Minimum Age: 15 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| RECOP unit patient<br>All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified. | Other: RECOP unit patient<br>* All patients admit in RECOP unit for dyspnea can be included in this study if patient is agree. Then, doctor collects demographic variables, the usual history and treatments, the characteristics of the episode (symptomatology, evolution, treatment taken) and the data from the initial clinical examination will be identified.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Develop a predictive model of the risk of being COVID-19 for patients admitted to the emergency room for dyspnea | demographic variables, usual history and treatments, episode characteristics (symptomatology, evolution, treatment taken) and data from the initial clinical examination will be collected by doctor | inclusion day | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Describe the characteristics of patients admitted to reCOP units according to their virological status | The COVID-19 virological condition will be taken with PCR tests on naso-pharyngeal samples or on sputum for patients taking | 30 days | 
| Virological status | Virological status will be collected by a phone call at the patient | 30 days | 
| Mortality status | Mortality status will be collected by a phone call at the patient | 30 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
diagnostic strategy, COVID-19, acute dyspnea